Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Procell

Home DrugsProcell

Procell

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

DEVELOPMENT OF NOVEL MACROMOLECULE TRANSDUCTION DOMAIN WITH IMPROVED CELL PERMEABILITY AND METHOD FOR USING SAME
EP 2784081 B1Applicant: PROCELL THERAPEUTICS INCPriority: 2011
EP
US
WO
6 publications
NOVEL MACROMOLECULE TRANSDUCTION DOMAINS AND METHODS FOR IDENTIFICATION AND USES THEREOF
US 2010197598 A1Applicant: PROCELL THERAPEUTICS INCPriority: 2008
US
4 publications
ESTABLISHMENT OF INDUCED PLURIPOTENT STEM CELL USING CELL-PERMEABLE REPROGRAMMING TRANSCRIPTION FACTOR FOR CUSTOMIZED STEM CELL THERAPY
US 2012095188 A1Applicant: JO DAEWOONGPriority: 2010
CN
US
2 publications
UROLITHIN B FOR MUSCLE GROWTH
US 2016045472 A1Applicant: PROCELL SPRLPriority: 2013
US
WO
2 publications
COMBINED USE OF CELL PERMEABLE NANOG AND OCT4 FOR INCREASING SELF-RENEWAL AND SUPPRESSING DIFFERENTIATION OF STEM CELLS
US 2010099144 A1Applicant: PROCELL THERAPEUTICS INCPriority: 2008
US
2 publications
CELL PERMEABLE P18 RECOMBINANT PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME, AND ANTICANCER COMPOSITION COMPRISING THE SAME
US 2010305041 A1Applicant: PROCELL THERAPEUTICS INCPriority: 2008
US
2 publications
CELL PERMEABLE NM23 RECOMBINANT PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME, AND ANTI-METASTATIC COMPOSITION COMPRISING THE SAME
US 2010323971 A1Applicant: PROCELL THERAPEUTICS INCPriority: 2008
US
2 publications
CELL-PERMEABLE ENDOSTATIN RECOMBINANT PROTEIN, A POLYNUCLEOTIDE ENCODING THE SAME, AND AN ANTI-CANCER PREPARATION CONTAINING THE SAME AS AN ACTIVE COMPONENT
US 2011092441 A1Applicant: PROCELL THERAPEUTICS INCPriority: 2009
US
2 publications
Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient
US 8470971 B2Applicant: JO DAEWOONGPriority: 2009
US
2 publications
Production of recombinant therapeutic bioscavengers against chemical and biological agents
US 2007111279 A1Applicant: PROCELL INCPriority: 2002
US

Page 1 of 2